Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3786
Title: Neural Correlates of Sleep Recovery following Melatonin Treatment for Pediatric Concussion: A Randomized Controlled Trial
Authors: Iyer, K. K.
Cocchi, L.
Barlow, Karen 
Zalesky, A.
Issue Date: 2020
Source: 37, (24), 2020, p. 2647-2655
Pages: 2647-2655
Journal: Journal of Neurotrauma
Abstract: Evidence-based treatments for children with persistent post-concussion symptoms (PPCS) are few and limited. Common PPCS complaints such as sleep disturbance and fatigue could be ameliorated via the supplementation of melatonin, which has significant neuroprotective and anti-inflammatory properties. This study aims to identify neural correlates of melatonin treatment with changes in sleep disturbances and clinical recovery in a pediatric cohort with PPCS. We examined structural and functional neuroimaging (fMRI) in 62 children with PPCS in a randomized, double-blind, placebo-controlled trial of 3 mg or 10 mg of melatonin (NCT01874847). The primary outcome was the total youth self-report Post-Concussion Symptom Inventory (PCSI) score after 28 days of treatment. Secondary outcomes included the change in the sleep domain PCSI score and sleep-wake behavior (assessed using wrist-worn actigraphy). Whole-brain analyses of (1) functional connectivity (FC) of resting-state fMRI, and (2) structural gray matter volumes via voxel-based morphometry were assessed immediately before and after melatonin treatment and compared with placebo to identify neural effects of melatonin treatment. Increased FC of posterior default mode network (DMN) regions with visual, somatosensory, and dorsal networks was detected in the melatonin groups over time. The FC increases also corresponded with reduced wake periods (r =-0.27, p = 0.01). Children who did not recover (n = 39) demonstrated significant FC increases within anterior DMN and limbic regions compared with those who did recover (i.e., PCSI scores returned to pre-injury level, n = 23) over time, (p = 0.026). Increases in GM volume within the posterior cingulate cortex were found to correlate with reduced wakefulness after sleep onset (r =-0.32, p = 0.001) and sleep symptom improvement (r = 0.29, p = 0.02). Although the melatonin treatment trial was negative and did not result in PPCS recovery (with or without sleep problems), the relationship between melatonin and improvement in sleep parameters was linked to changes in function-structure within and between brain regions interacting with the DMN.L6337427372020-12-29
2021-01-05
DOI: 10.1089/neu.2020.7200
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L633742737&from=exporthttp://dx.doi.org/10.1089/neu.2020.7200 |
Keywords: major clinical study;male;nerve function;neuroimaging;neurologic disease assessment;outcome assessment;pediatrics;Post Concussion Symptom Inventory score;randomized controlled trial;self report;sleep disorder;sleep waking cycle;somatosensory system;traumatic brain injury;sleep;NCT01874847melatonin;placebo;actimetry;adolescent;article;brain region;brain size;concussion;controlled study;convalescence;default mode network;double blind procedure;female;functional magnetic resonance imaging;gray matter;human
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

72
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.